The largest database of trusted experimental protocols

Plzf 9e12

Manufactured by BioLegend

PLZF (9E12) is a monoclonal antibody that recognizes the PLZF (Promyelocytic Leukemia Zinc Finger) protein. PLZF is a transcriptional regulator involved in the development and differentiation of various cell types. This antibody can be used for the identification and characterization of PLZF-expressing cells in research applications.

Automatically generated - may contain errors

3 protocols using plzf 9e12

1

Multiparameter Flow Cytometric Analysis of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were prepared from the indicated tissues and stained with fluorescence-conjugated antibodies as previously described (26 (link)). The data were acquired using LSR Fortessa or LSRII flow cytometers (BD Biosciences) and were analyzed using software platforms developed by the EIB Flow Cytometry Facility, CCR, NCI, NIH. Live cells were gated by forward scatter exclusion of dead cells stained with propidium iodide. The following antibodies were used for staining: HSA (M1/69), T-bet (4B10), Foxp3 (FJK-16s), RORγt (AKFJS-9) and isotype control antibodies, all from eBioscience; CD4 (GK1.5 and RM4.5), CD8α (53–6–7), CD69 (H1.2F3), TCRβ (H57-597) and IL2Rβ (TM-β1) from BD Biosciences; CD44 (IM7), NK1.1 (PK136), IL2Rα (PC61), CCR7 (4B12) and PLZF (9E12) from BioLegend. Fluorochrome-conjugated CD1d tetramers loaded with PBS-57 (CD1dTet) and unloaded controls were obtained from the NIH tetramer facility (Emory University, Atlanta, GA). Intracellular Foxp3, PLZF, RORγt, and T-bet proteins were detected using a Foxp3 staining kit according to the manufacturer’s instructions (eBioscience Thermo Fisher).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis of Mouse Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow-cytometric analyses, mAbs specific for mouse CD3ε (145-2C11), CD8α (53–6.7), CD19 (1D3), B220 (RA3-6B2), NK1.1 (PK136), CD11b (M1/70), CD11c (HL3), Gr-1 (RB6-8C5), TER119 (TER119), CD45.1 (A20), CD45.2 (2F1), Sca-1 (E13-161.7), CD25 (PC61), Thy1.2 (53–2.1), Flt3 (A2F10), α4β7 (DATK32), KLRG1 (2F1), CCR9 (CW-1.2), CD31 (MEC13.3), GATA3 (L50-823), T-bet (O4-46), RORγt (Q31-378), IFN-γ (XMG1.2), IL-17A (TC11-18H10), and fluorochrome-conjugated streptavidin were purchased from BD. mAbs against mouse Notch1 (HMN1-12), Notch2 (HMN2-35), CD4 (GK1.5), PDGFRα (ATA5), gp38 (8.1.1), and PLZF (9E12) were purchased from BioLegend. mAbs against c-Kit (2B8), FcεRIα (MAR-1), IL-7Rα (A7R34), and IL-13 (eBio13A) were purchased from eBioscience. Anti-T1/ST2 (DJ8) was purchased from MD Biosciences. mAb against mouse CD16/CD32 (2.4G2) was purified from hybridoma culture supernatants in our laboratory.
Recombinant mIL-2, mIL-7, mIL-25, mIL-33, and mTSLP were purchased from R&D Systems. A STAT5 inhibitor (CAS 285986–31-4) was purchased from Calbiochem, and Dox was purchased from Clontech.
+ Open protocol
+ Expand
3

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescence-conjugated antibodies with the following specificities were used to detect antigens by flow cytometry: CD4 (GK1.5), CD8α (53-6-7), IL-4Rα (M1), CD44 (IM7), γδT cell receptor (GL3), γc (4G3), RORγt (Q31-378), Runx3 (R3-5G4), pSTAT1 (pY701; 4a), and isotype control antibodies, all from BD Biosciences; CD24 (M1/69), IL-2Rβ (TM-β1), IL-7Rα (A7R34), IFNGR1 (2E2), Eomes (Dan11mag), IL-4 (11B11), IL-17 (eBio17B7) and T-bet (4B10) from Invitrogen; CXCR3 (CXCR3-173), TCRβ (H57-597), IFNγ (XMG1.2), Ikaros (2A9), and PLZF (9E12) from Biolegend. CD1d tetramers loaded with PBS-57 were obtained from the NIH tetramer facility (Emory University, Atlanta, GA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!